Related Experiment Video
Updated: Apr 26, 2026

08:16
Movement Retraining using Real-time Feedback of Performance
Published on: January 17, 2013
12.7K
Practice, progress and future directions for physical therapies in Huntingtons disease
Monica Busse1, Hanan Khalil2, Simon Brooks3
1School of Health Care Studies, Cardiff University, Cardiff, UK. busseme@cardiff.ac.uk
Journal of Huntington'S Disease
|July 27, 2014
Summary
Physical therapy and exercise show promise for Huntington
Area of Science:
- Neurology
- Physical Therapy
- Exercise Science
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Physical interventions are being explored for their potential disease-modifying effects in HD.
- Previous small-scale studies suggest benefits from physical activity and exercise in HD patients.
Purpose of the Study:
- To conduct a narrative review of existing literature on physical activity, physical therapy, and exercise in individuals with Huntington's disease.
- To evaluate the reporting standards of physical intervention studies in HD.
- To identify areas for improvement in the design and reporting of future clinical trials.
Main Methods:
- A narrative literature review was performed using a Population, Intervention, Comparison, Outcome (PICO) approach.
- Eight studies meeting specific inclusion criteria were systematically reviewed.
- Studies were assessed for their conduct and reporting standards, including intervention details, adherence, and adverse events.
Main Results:
- All eight reviewed studies detailed intervention components, location, and duration.
- Most interventions involved balance training and activities of daily living, requiring therapist supervision.
- Reporting on adherence rates (60-80% in 3/8 studies) and adverse events was limited, with no adverse events reported in any study.
Conclusions:
- While physical therapies show potential in Huntington's disease management, clearer reporting of intervention protocols is crucial.
- Improved reporting standards will enhance understanding of exercise and physical therapy impacts on HD symptoms.
- Standardized reporting is essential for future trial replication and clinical implementation, especially alongside emerging disease-modifying treatments.
Related Concept Videos
Huntington Disease l: Introduction
68
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
68
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease ll: Pathophysiology
20
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
20
Parkinson Disease l: Introduction
18
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
18

